27 related articles for article (PubMed ID: 38635248)
1. Regulatory T-cell depletion in the setting of autologous stem cell transplantation for multiple myeloma: pilot study.
Derman BA; Zha Y; Zimmerman TM; Malloy R; Jakubowiak A; Bishop MR; Kline J
J Immunother Cancer; 2020 Jan; 8(1):. PubMed ID: 31940591
[TBL] [Abstract][Full Text] [Related]
2. Regulatory T cells suppress myeloma-specific immunity during autologous stem cell mobilization and transplantation.
Takahashi S; Minnie SA; Ensbey KS; Schmidt CR; Sekiguchi T; Legg SRW; Zhang P; Koyama M; Olver SD; Collinge AD; Keshmiri S; Comstock ML; Varelias A; Green DJ; Hill GR
Blood; 2024 Apr; 143(16):1656-1669. PubMed ID: 38295333
[TBL] [Abstract][Full Text] [Related]
3. Autologous stem cell transplantation in children with severe progressive systemic or polyarticular juvenile idiopathic arthritis: long-term follow-up of a prospective clinical trial.
Brinkman DM; de Kleer IM; ten Cate R; van Rossum MA; Bekkering WP; Fasth A; van Tol MJ; Kuis W; Wulffraat NM; Vossen JM
Arthritis Rheum; 2007 Jul; 56(7):2410-21. PubMed ID: 17599770
[TBL] [Abstract][Full Text] [Related]
4. T-cell Exhaustion in Multiple Myeloma Relapse after Autotransplant: Optimal Timing of Immunotherapy.
Chung DJ; Pronschinske KB; Shyer JA; Sharma S; Leung S; Curran SA; Lesokhin AM; Devlin SM; Giralt SA; Young JW
Cancer Immunol Res; 2016 Jan; 4(1):61-71. PubMed ID: 26464015
[TBL] [Abstract][Full Text] [Related]
5. Regulatory T-cell depletion in angioimmunoblastic T-cell lymphoma.
Bruneau J; Canioni D; Renand A; Marafioti T; Paterson JC; Martin-Garcia N; Gaulard P; Delfau MH; Hermine O; Macintyre E; Brousse N; Asnafi V
Am J Pathol; 2010 Aug; 177(2):570-4. PubMed ID: 20566750
[TBL] [Abstract][Full Text] [Related]
6. Treg depletion supercharges ASCT power.
Bruns H
Blood; 2024 Apr; 143(16):1562-1563. PubMed ID: 38635248
[No Abstract] [Full Text] [Related]
7. Can you rely on Treg cells on the rebound?
Teh CE; Gray DH
Eur J Immunol; 2014 Dec; 44(12):3504-7. PubMed ID: 25410151
[TBL] [Abstract][Full Text] [Related]
8. Stem cell transplantation for multiple sclerosis: what is the evidence?
Fassas A; Kimiskidis VK
Blood Rev; 2003 Dec; 17(4):233-40. PubMed ID: 14556778
[TBL] [Abstract][Full Text] [Related]
9. Autologous stem cell transplantation in follicular non-Hodgkin's lymphoma.
Pettengell R
Bone Marrow Transplant; 2002 Feb; 29 Suppl 1():S1-4. PubMed ID: 11840153
[TBL] [Abstract][Full Text] [Related]
10. Progress and prospect of ASCT combined with CAR-T therapy in the treatment of multiple myeloma.
Yuan S; Chen Y; Liu H
Ther Adv Hematol; 2024; 15():20406207241237594. PubMed ID: 38481949
[TBL] [Abstract][Full Text] [Related]
11. Regulatory T cells in melanoma: the final hurdle towards effective immunotherapy?
Jacobs JF; Nierkens S; Figdor CG; de Vries IJ; Adema GJ
Lancet Oncol; 2012 Jan; 13(1):e32-42. PubMed ID: 22225723
[TBL] [Abstract][Full Text] [Related]
12. Autologous Hematopoietic Stem Cell Transplantation in Acute Myelogenous Leukemia.
Zhao Y; Chen X; Feng S
Biol Blood Marrow Transplant; 2019 Sep; 25(9):e285-e292. PubMed ID: 31054985
[TBL] [Abstract][Full Text] [Related]
13.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
14.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
